Article

Engineered ACE2 counteracts vaccine-evading SARS-CoV-2 Omicron variant

medRxiv · 2022 · Ikemura, N.; Taminishi, S.; Inaba, T.; Arimori, T.; Motooka, D.; Katoh, K.; Kirita, Y.; Kirita, Y.; Li, S.; Suzuki, T.; Itoh, Y.; Ozaki, Y.; Nakamura, S.; Matoba, S.; Standley, D. M.; Okamoto, T.; Takagi, J.; Hoshino, A.

Key facts

Title Engineered ACE2 counteracts vaccine-evading SARS-CoV-2 Omicron variant
First author Ikemura, N.; Taminishi, S.; Inaba, T.; Arimori, T.; Motooka, D.; Katoh, K.; Kirita, Y.; Kirita, Y.; Li, S.; Suzuki, T.; Itoh, Y.; Ozaki, Y.; Nakamura, S.; Matoba, S.; Standley, D. M.; Okamoto, T.; Takagi, J.; Hoshino, A.
Journal medRxiv
Published Feb 22, 2022
DOI 10.1101/2021.12.22.473804
Devices mentioned BK110039, DEN000008, K022086, K103302, K202641, K231013, K822496
Product codes mentioned JCI, KIP, KIT, NDS, NJT, OOI, PFF, PFT, JIT, PCA, QBD

At a glance

  • 1–9 FDA submissions mentioned
  • 10–99 Product codes mentioned

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About Literature

Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.

Source: Publisher and PubMed metadata; device mentions identified by Orca1

Browse all Literature